Clin2
NCT06800950Likely a fitNot yet recruiting

Quadrivalent flu vaccine trial for ages 3 and up

Influenza, HumanInfluenza, Human PreventionInfluenza aInfluenza BInfluenza Viral Infections

Part of Infections, Lungs & breathing clinical trials.

This trial tests a new quadrivalent flu vaccine in people aged 3 years and older. It aims to see if the vaccine is safe and effective at preventing the flu. You may join if you have received a flu shot in the past year (if aged 3–8) or have not had a flu shot in the past year (if older than 3).

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
4,400 people
Ages
3 years and older
Study type
Interventional

Who can take part

  • You must be at least 3 years old.
  • You need to provide a valid ID and sign a consent form.
  • You must agree to use birth control for 6 months after vaccination.
  • Your underarm temperature must be below 99.1°F (37.3°C).
  • You cannot have a severe egg allergy or any allergy to vaccine ingredients.
  • You must not have had the flu in the last 6 months or a flu shot in the last year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06824519Recruiting· Phase 1/Phase 2
Quadrivalent flu vaccine trial for adults

This trial tests a new quadrivalent influenza (flu) vaccine in adults 18 and older. It aims to see if the vaccine is safe and helps protect against the flu. You may be able to join if you are generally healthy and have not had the flu or a flu shot recently.

Shijiazhuang, Hebei
NCT07327398Not yet recruiting· Phase 2
Flu vaccine trial for adults 60 and older

This trial tests a flu vaccine (split virus type) for adults aged 60+ to see how well it works and how safe it is. It might help protect older adults from the flu.

Wuhan, Hubei
NCT07302256Recruiting· Phase 1
Flu vaccine trial for adults 60 and older

This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.

Wuhan, Hubei
NCT07431853Recruiting· Phase 2
Study of an mRNA flu vaccine for adults

This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.

Mobile, Alabama
NCT07703514Not yet recruiting· Phase 1
Experimental flu vaccine safety study

This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.

Baltimore, Maryland
NCT07349017Not yet recruiting· Phase 1
Testing a flu vaccine with adjuvant in adults

This trial tests a new flu vaccine with an ingredient to boost your immune response. It's for adults who haven't had the flu or a flu shot in the past 6 months and are generally healthy.

Hear when a new Influenza, Human trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.